Your Host
Larry Cohen

Larry Cohen is the host of Ringler Radio and is the head of Ringler Associates operations in the Northeast....

Episode Notes

Medical devices and pharmaceutical drugs undergo rigorous testing and must receive pre‑market approval from the FDA before they are available to the public. Unfortunately, all too often, defects and severe side effects that may or may not have been latent during testing and trials create hazardous products. On Ringler Radio, host Larry Cohen welcomes colleague and co-host Ann Marie VonBank and guest, Attorney James T. Capretz, to discuss the current litigation against the makers of some of the most dangerous drugs and medical devices.

Newsletter

Notify me when there’s a new episode!

Episode Details
Published: April 18, 2011
Podcast: Ringler Radio
Podcast
Ringler Radio
Ringler Radio

Ringler Radio presents an unprecedented analysis of the latest news impacting the structured settlement profession.

Listen & Subscribe
Recent Episodes
01/07/20
Structured Installment Sales

Larry Cohen and guest and Ringler colleague, Phillip Krause discuss the benefits and advantages of going with a structured installment sale, and the reasons...

12/09/19
Inside the Vegas Shootings Settlement

Mo Aziz discusses the settlement of the vegas shooting, the liability and negligence of MGM, and how this human tragedy led to a relatively...

11/18/19
Technology in the Alternative Dispute Resolution Arena

Hon. Elizabeth Bonina takes a look at the use of technology in the Alternative Dispute Resolution arena and discusses how technology is improving the...

11/04/19
Inside the Controversial Purdue Pharma Settlement

Jonathan Novak discuss Purdue Pharma’s bankruptcy filing and whether the remaining 25 states will agree to a settlement or take their fight to the courts.

10/24/19
Labor Shifts Impact on the Workers’ Compensation Industry

Larry Cohen and Alan Pierce take a look at the history of workers’ comp and discuss technology’s impact on the workplace.

09/23/19
JUUL Litigation

Joseph VanZandt discusses the recent news on sales, marketing, and labeling against JUUL, and how they've failed to warn off the products’ with high...